PAPER Daulatzai MA
SEARCH RESULTS
330907 RESULTS
PAPER Choi J, Twamley EW
Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy.
Neuropsychol Rev. 2013 Mar;23(1):48-62. PubMed: 23400790PAPER Kenche VB, Hung LW, Perez K, Volitakes I, Ciccotosto G, Kwok J, Critch N, Sherratt N, Cortes M, Lal V, Masters CL, Murakami K, Cappai R, Adlard PA, Barnham KJ
Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease.
Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3374-8. PubMed: 23401085PAPER Akoury E, Pickhardt M, Gajda M, Biernat J, Mandelkow E, Zweckstetter M
Mechanistic basis of phenothiazine-driven inhibition of tau aggregation.
Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3511-5. PubMed: 23401175PAPER Zhang B, Tang XC, Zhang HY
Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
J Neurosci Res. 2013 May;91(5):717-25. PubMed: 23401344PAPER Garai K, Frieden C
Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ.
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3321-6. PubMed: 23401512PAPER He J, Li X, Yang J, Huang J, Fu X, Zhang Y, Fan H
The association between the methionine/valine (M/V) polymorphism (rs1799990) in the PRNP gene and the risk of Alzheimer disease: an update by meta-analysis.
J Neurol Sci. 2013 Mar 15;326(1-2):89-95. PubMed: 23399523PAPER Kingwell K
Alzheimer disease: modified Salmonella toxin combats Alzheimer disease in mouse model.
Nat Rev Neurol. 2013 Mar;9(3):120. PubMed: 23399645PAPER Chételat G
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.
Nat Rev Neurol. 2013 Mar;9(3):123-4. PubMed: 23399647PAPER Ghochikyan A, Davtyan H, Petrushina I, Hovakimyan A, Movsesyan N, Davtyan A, Kiyatkin A, Cribbs DH, Agadjanyan MG
Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits.
Hum Vaccin Immunother. 2013 Feb 11;9(5) PubMed: 23399748PAPER Zhang ZY, Schluesener HJ
Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model.
J Neuropathol Exp Neurol. 2013 Mar;72(3):178-85. PubMed: 23399896PAPER Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, Zommer N, Hamdane M, Bellenguez C, Dartigues JF, Hauw JJ, Letronne F, Ayral AM, Sleegers K, Schellens A, Broeck LV, Engelborghs S, De Deyn PP, Vandenberghe R, O'Donovan M, Owen M, Epelbaum J, Mercken M, Karran E, Bantscheff M, Drewes G, Joberty G, Campion D, Octave JN, Berr C, Lathrop M, Callaerts P, Mann D, Williams J, Buée L, Dewachter I, Van Broeckhoven C, Amouyel P, Moechars D, Dermaut B, Lambert JC, GERAD consortium
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
Mol Psychiatry. 2013 Nov;18(11):1225-34. Epub 2013 Feb 12 PubMed: 23399914PAPER Bennett DA
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
Neurology. 2013 Feb 12;80(7):690. PubMed: 23400321PAPER Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, Decarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
JAMA Neurol. 2013 Apr 1;70(4):488-95. PubMed: 23400560PAPER Zlokovic BV
Cerebrovascular effects of apolipoprotein e: implications for Alzheimer disease.
JAMA Neurol. 2013 Apr 1;70(4):440-4. PubMed: 23400708Current Filters
No filters selected